Radiofrequencyablation (RFA) is presented as a novel axillary, ulnar, and other peripheral nerves (unpublished data, Wood BJ, 2002). Maintaining temperatures below method to treat lytic metastases to the spine, which can present a difficult therapeutic dilemma. As a feasibility 457C in adjacent nerve tissue for short periods should prevent unwanted nerve damage. study, the short series by Grö nemeyer et al 1 is only the first clinical step in the definition of indications and in
lower-risk patient population, without these features, 27, 2001. might have proved a more defendable result. The spec-The author has received or will receive benefits for personal or profestrum of treated tumor histology is also broad. This study sional use from a commercial par ty related directly or indirectly to the subject of this ar ticle. Dr. Wood is an unpaid research consultant for does not mention that there are few data on the differing Radionics, Inc., and receives equipment suppor t from Radionics, Inc., dielectrics of tumor tissues. Even simple tissue vascu-RITA Medical, Inc., and Radiotherapeutics Corp. He also owns privately purchased stock in Boston Scientific, which owns Radiotherapeutics larity has broad implications on thermal and electrical Corp. conductivity and on resulting thermal lesion profiles. A Was the study approved by an investigational review 26 board? This is a controversial issue because three RFA could also be stated; the nondeployable water-cooled system could allow more precise and controlled RFA systems are United States Food and Drug Administration 510K-cleared for ''soft tissue ablation,'' and lytic metasta-without deployment of hooks in three dimensions, potentially into sensitive structures ( Fig. 1 ). Monitoring ses might be considered soft tissue. (This study was not conducted in the United States and was therefore not the three-dimensional simultaneous deployment of the hooks can also be difficult. The water-cooled system subject to Food and Drug Administration regulations.) The authors did not use sedation, which is a variation also has the advantage of being a smaller 17.5-gauge needle instead of a 14-or 15-gauge needle, as is the to standard RFA. This was for the sake of an accurate neurologic examination during the RFA. They state that case with the coaxial systems.
It cannot be overemphasized that RFA has a steep the electrodes can be comfortably placed. However, in our experience, the application of alternating current is learning curve. The techniques and principles prerequisite to successful and safe RFA should be mastered else-met with moderate to severe pain in most patients who are lightly sedated. The authors call RFA treatment pain where in the body, such as in the liver and in nonspinal bones (well away from nerves and other collateral struc-''very moderate local pain.'' 1 What does the ''very'' mean here? Is this worse than moderate? Did they ask the tures). RFA relies on technology that is recently in constant evolution. Operator experience may not have yet patients at the time of the RFA?
The techniques and the geometry of the thermal le-caught up with the rapid deployment of RFA systems in the community. Also, by the time an RFA study sion are unspecified and incomplete. The authors state, ''depending on the tumor' s distance to the spinal cord, reaches press, there are often more recent models or advancements that render the conclusions somewhat the power output was slowly increased,'' without defining that distance. 1 In fact, these results are not reproducible, because needle location, ramping time, stopping points, cooling times, and dielectric measurements, such as impedance, are all unspecified. No imaging outcomes criteria are defined, and the methods are not reproducible without more information. For example, the authors produced thermal lesions up to 9 cm in diameter but repositioned the probe (and changed the location of the resulting 3-cm thermal lesion) only two to three times. 1 Computer modeling of overlapping thermal spheres suggests that a 3-cm probe could yield only a 3.75-cmdiameter sphere without untreated tumor gaps, even with six perfectly overlapped RFA sessions. 5 The authors claim 9 cm thermal lesions with 2-3 spheres, which is mathematically impossible without gaps of untreated intervening tumor. How close to the margin of the tumor did they go, and how close was this to major nerves?
There are several inaccuracies in this study that need clarification. The 50-W generator (Rita Medical Systems Inc., Mountain View, CA) has been replaced by a 150-W variety, and the 3-cm probe has been replaced by a 5-cm probe, and even more recently a 7-cm, treeshape probe. Other systems have 200 W. The low-wattage system used in this study may fortuitously make complications less likely in the spine, where temperature and thermal lesion volume should not be maximized, because of proximity of nerves. Also, at least three different systems are actually marketed for tumor RFA, not FIGURE 1 Alternative method of radiofrequency thermal ablatwo, as stated. One is water cooled (Radionics, Inc, tion of a spinal tumor using the water-cooled system, which uses a smaller needle (17.5 G) but does not have as many thermistors Burlington, MA), one is coaxial and temperature con- obsolete. This complicates interpretation of results and this brief window for study. I hope that interested surgeons, interventional radiologists, oncologists, and engialso complicates randomization against other competing neers rise to the task, before spinal RFA becomes more therapies. Controlling a study also may present ethical widespread clinical practice simply by default. dilemmas. For example, in light of this study, would it now be unethical to have a control group and withhold spinal RFA from a patient without other options who R E F E R E N C E S might benefit from this treatment? When in doubt, early spinal cord or peripheral nerves even in immediate prox-We appreciate Dr. Wood' s comments regarding our artiimity of the RF probe to these sensitive structures. In cle ''Image-guided Radiofrequency Ablation of Spinal our group of patients, one patient reported pain and Tumors: Preliminary Experience with an Expandable hypesthesia during the treatment in the contralateral Array Electrode'' published in the current issue of The leg. After immediately reducing the temperature, these Cancer Journal. We would like to respond to his comsymptoms disappeared. In our experience with a dements as follows. ployable RFA electrode system in parenchymal tissue, Indeed, image-guided radiofrequency ablation (RFA) the system produces a relatively homogeneous spherical may be a promising method for the treatment of unrelesion that involves tissue 2-5 mm beyond the elecsectable tumors, especially of metastases to the spine. trode' s tip (experimental work in progress). We hypothe-Our work introduces the procedure for this indication size that the relevant features of parenchymal tissue and demonstrates its feasibility and safety when perare comparable to those of osteolytic or mixed spinal formed under image-guidance and strict patient selecmetastases. Dr. Wood raises the issue of thermal distribution. With our report on 10 patients, we hope to take tion in cases of an absent or lytic posterior vertebral a first step in defining inclusion and exclusion criteria body cortex or a widened neural foramen. We certainly and encourage other colleagues to gather their own agree that this may present additional risk. This issue experiences and contribute to the development of this should be subject to further investigation and discusmethod. sion. To cause a lesion in thoroughly vascularized tu-RFA heating tissue causes cell damage between 457C mors, such as renal cell carcinoma, higher temperatures and 607C, which is considered to be reversible. Tissue clearly are required. For this purpose, tissue impedance heating of more than 607C for at least 2 minutes will and changes in impedance may be good indicators for cause irreversible cell damage. It is highly probable that the parameters to be chosen. Surely, standardized tumor temperature controlled RF-systems with thermocouples specific parameters will have to be defined in the future. provide more safety than impedance controlled RF-In our experience, vertebroplasty immediately after systems without thermocouples, because they enable RFA is a very painful procedure for non-sedated patients. temperature monitoring during the ablation. We recom-In our institution, patients who received vertebroplasty mend gradually increasing the temperature to obtain immediately after RFA and were treated only under local minimal impedance, and thus acquire adequate heat anesthesia reported severe local pain sometimes with flow. Moderate increase of temperature (to 507C in the radicular pain radiation during the injection of the cefirst 2 minutes, then 7.57C increase every minute until ment. The reason may lie in increased intervertebral pressure as a result of tissue steam after RFA. target temperature is reached or pain becomes intoler-
